×

Please Remove Adblock
Adverts are the main source of Revenue for DoveMed. Please remove adblock to help us create the best medical content found on the Internet.

One E-Cigarette With Nicotine Leads To Adrenaline Changes In Nonsmokers' Hearts

Last updated Sept. 22, 2017

Approved by: Maulik P. Purohit MD MPH

Brandon Blinkenberg

Electronic cigarettes have been touted as both a safer alternative for smokers and as an effective way for people to gradually quit smoking altogether. But a new study shows that nicotine inhaled from e-cigarettes can greatly increase a person's heart rate and aggravate the sympathetic nervous system.


A new UCLA study found that healthy nonsmokers experienced increased adrenaline levels in their heart after one electronic cigarette (e-cigarette) with nicotine but there were no increased adrenaline levels when the study subjects used an a nicotine-free or empty e-cig.

The findings are published in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.

Unlike cigarettes, e-cigs have no combustion or tobacco. Instead, these electronic, handheld devices deliver nicotine with flavoring and other chemicals in a vapor instead of smoke.

"While e-cigarettes typically deliver fewer carcinogens than are found in the tar of tobacco cigarette smoke, they also usually deliver nicotine. Many believe that the tar -- not the nicotine -- is what leads to increased cancer and heart attack risks," said Dr. Holly R. Middlekauff, senior study author and professor of medicine (cardiology) and physiology at the David Geffen School of Medicine at UCLA. "So, we asked the question, are e-cigarettes safe?"

The researchers had previously reported that chronic e-cig users have elevated sympathetic nerve activity which increases adrenaline directed to the heart and are more susceptible to oxidative stress. Both are risks factors for heart attack. This study aimed to find out if nicotine caused these events.

Middlekauff and her team used a technique called "heart rate variability" obtained from a prolonged, non-invasive heart rhythm recording. Heart rate variability is calculated from the degree of variability in the time between heartbeats. This variability may be indicative of the amount of adrenaline on the heart.

Prior studies have used a heart rate variability test to link increased adrenaline activity in the heart with increased cardiac risk. People with known heart disease and people without known heart disease who have this pattern of high adrenaline levels in the heart have increased risk of death, Middlekauff said.

In the first study to separate the nicotine from the non-nicotine components when looking at the heart impact of e-cigarettes on humans, researchers studied 33 healthy adults who were not current e-cigarette or tobacco cigarette smokers. On different days, each participant used an e-cigarette with nicotine, an e-cigarette without nicotine or an empty 'sham' device. Researchers measured cardiac adrenaline activity by assessing heart rate variability and oxidative stress in blood samples by measuring the enzyme plasma paraoxonase (PON1).

They found:

  • Exposure to e-cigarettes with nicotine, but not e-cigarettes without nicotine, led to increased adrenaline levels to the heart, as indicated by abnormal heart rate variability.
  • Oxidative stress, which increases risks for atherosclerosis and heart attack, showed no changes after exposure to e-cigarettes with and without nicotine. The number of markers they studied for oxidative stress were minimal, however and more studies are warranted, according to Middlekauff.

"While it's reassuring that the non-nicotine components do not have an obvious effect on adrenaline levels to the heart, these findings challenge the concept that inhaled nicotine is benign, or safe. Our study showed that acute electronic cigarette use with nicotine increases cardiac adrenaline levels. And it's in the same pattern that is associated with increased cardiac risk in patients who have known cardiac disease, and even in patients without known cardiac disease," Middlekauff said. "I think that just seeing this pattern at all is very concerning and it would hopefully discourage nonsmokers from taking up electronic cigarettes."

Future studies should look more closely at oxidative stress and e-cigarette use, using a broader number of cardiac markers, in a larger population of people, researchers said.

Co-authors are Roya S. Moheimani; May Bhetraratana; Kacey M. Peters; Benjamin K. Yang; Fen Yin; Jeffrey Gornbein and Dr. Jesus A. Araujo, all from UCLA. Author disclosures are on the manuscript.

The Tobacco-Related Disease Research Program; American Heart Association, Western States Affiliate; National Institute of Environmental Health Sciences, National Institutes of Health; Irma and Norman Switzer Dean's Leadership in Health and Science Scholarship; and UCLA Clinical and Translational Science Institute funded the study.


Materials provided by UCLA HealthNote: Content may be edited for style and length.

Disclaimer: DoveMed is not responsible for the accuracy of the adapted version of news releases posted to DoveMed by contributing universities and institutions.

References:

Roya S. Moheimani, May Bhetraratana, Kacey M. Peters, Benjamin K. Yang, Fen Yin, Jeffrey Gornbein, Jesus A. Araujo, Holly R. Middlekauff. (2017). Sympathomimetic Effects of Acute E‐Cigarette Use: Role of Nicotine and Non‐Nicotine ConstituentsJournal of the American Heart Association. DOI: 10.1161/JAHA.117.006579

Reviewed and Approved by a member of the DoveMed Editorial Board
First uploaded: Sept. 22, 2017
Last updated: Sept. 22, 2017